Steven Keith Burke
CIK 1619834 · SVP, Chief Medical Officer · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$936.9K
Companies
2
Total Filings
43
Lifetime Open-Market Net
-$341.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 5
43 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-29 | AKBA | Notice (144) | −7,169 | -$11.3K | EDGAR |
| 2024-02-27 | AKBA | Notice (144) | −8,367 | -$12.7K | EDGAR |
| 2024-02-02 | AKBA | Mixed | +177,889 | -$40.8K | EDGAR |
| 2024-02-01 | AKBA | Notice (144) | −24,311 | -$40.8K | EDGAR |
| 2023-05-18 | AKBA | Sell (S) | −63,567 | -$67.9K | EDGAR |
| 2023-05-16 | AKBA | Notice (144) | −63,567 | -$67.9K | EDGAR |
| 2023-03-03 | AKBA | Sell (S) | −14,123 | -$12.4K | EDGAR |
| 2023-03-01 | AKBA | Sell (S) | −7,539 | -$6.1K | EDGAR |
| 2023-02-02 | AKBA | Grant (A) | +196,200 | $0 | EDGAR |
| 2022-09-01 | AKBA | Sell (S) | −1,147 | -$416 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.